We could not find any results for:
Make sure your spelling is correct or try broadening your search.
NEW YORK, June 25 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) opened trading on Safety First Trust Series 2008-2's Principal-Protected Trust Certificates Linked to the S&P 500...
AMS Health Sciences, Inc., (AMEX:AMM), today announced a net?loss for the first quarter 2007 of ($410,339), or ($0.05) per common (diluted) share, on 8.5 million shares...
AMS Health Sciences, Inc., (AMEX: AMM), announces its first quarter earnings will be released Friday, May 11, 2007. The AMS first quarter earnings conference call will be held:...
Dr. Jerry Grizzle, Chairman of the Board, President and Chief Executive Officer for AMS Health Sciences (AMEX: AMM), a leading direct selling company, announces the launch of...
AMS Health Sciences, Inc. (AMEX:AMM) announced today the appointment of Lawrence R. Moreau to the Board of Directors. Mr. Moreau was appointed by unanimous written consent. Mr...
AMS Health Sciences, Inc (AMEX:AMM) announced today the nomination and election of Richard C. Wiser to the Board of Directors. Mr. Wiser was elected by unanimous written...
AMS Health Sciences, Inc. (AMEX:AMM) announced the execution of certain lease and purchase agreements between Heartland Cup Inc. and Republic Plastics Ltd. (collectively, the...
AMS Health Sciences, Inc., (Amex: AMM), today announced a net?loss from continuing operations for the third quarter 2006 of $583,299, or $0.07 per common share, on 7.8 million...
AMS Health Sciences, Inc., (AMEX: AMM - News), will release 2006 third quarter results on Tuesday, November 14, 2006. The Company will host a conference call to discuss these...
AMS Health Sciences, Inc. (AMEX:AMM) today announced that it will be exhibiting and presenting at the ValueRich Small-Cap Financial Expo at the Wynn Las Vegas Resort. Dr...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions